FDA approves pooled coronavirus testing in hopes of boosting testing capacity

Coronavirus testing.
(Image credit: Mario Tama/Getty Images)

In an effort to ease the diagnostic logjam the United States is facing with the coronavirus surging in various parts of the country, the Food and Drug Administration on Saturday granted an emergency use authorization for pooled COVID-19 testing.

Quest Diagnostics will now be able to group up to four samples together and will only test them individually if the batch comes back positive. This approach — which has been used in Germany, China, Israel, and South Africa, among other countries — can help save valuable time and resources during the pandemic.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.